Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present T2 Biosystems, Inc. (NASDAQ: TTOO).

Full DD Report for TTOO

You must become a subscriber to view this report.


Recent News from (NASDAQ: TTOO)

T2 Biosystems' (TTOO) CEO John McDonough on Q1 2018 Results - Earnings Call Transcript
T2 Biosystems (TTOO) Q1 2018 Earnings Conference Call May 8, 2018 16:30 ET Executives Matt Clawson - Investor Relations John McDonough - President and Chief Executive Officer John Sprague - Chief Financial Officer Analysts Patrick Donnelly - Goldman Sachs Max Masucci - Ca...
Source: SeekingAlpha
Date: May, 14 2018 07:11
T2 Biosystems beats by $0.01, beats on revenue
T2 Biosystems (NASDAQ: TTOO ): Q1 EPS of -$0.36 beats by $0.01 . More news on: T2 Biosystems, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 08 2018 16:29
T2 Biosystems Reports First Quarter 2018 Financial Results and Provides Corporate Update
Quarterly Product Revenue Up 66% Year-Over-Year On Track for Potential FDA Clearance of T2Bacteria Panel in the Second Quarter 2018 LEXINGTON, Mass., May 08, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innova...
Source: GlobeNewswire
Date: May, 08 2018 16:01
T2 Biosystems Announces 2018 First Quarter Financial and Operational Results Release and Conference Call Date
LEXINGTON, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, today announced that it will release its 2018 first quarter f...
Source: GlobeNewswire
Date: April, 30 2018 08:00
Antimicrobials Working Group Highlights Member Company Participation at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
WASHINGTON , April 20, 2018 /PRNewswire/ -- The Antimicrobials Working Group (AWG) today announced that thirteen of its member companies will present data from their clinical and research programs at the annual meeting of the European Congress of Clinical Microbiology and Infectious ...
Source: PR Newswire
Date: April, 20 2018 10:17
T2 Biosystems Reports Granting of Inducement Awards
LEXINGTON, Mass., April 04, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on April 2, 2018 it issued inducement awa...
Source: GlobeNewswire
Date: April, 04 2018 16:05
Multiple New Studies Demonstrate T2 Biosystems' Diagnostics Improve Detection of Sepsis Causing Pathogens Over Blood Culture-based Diagnostics
LEXINGTON, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products, announces the publication of four new, peer-reviewed studies that demonstrate the clinical and pe...
Source: GlobeNewswire
Date: March, 28 2018 08:30
T2 Biosystems to Present at the 17th Annual Needham Healthcare Conference
LEXINGTON, Mass., March 19, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, today announced that John McDonough, president and chief execu...
Source: GlobeNewswire
Date: March, 19 2018 16:05
After Hours Gainers / Losers (3/9/2018)
Top gainers: CEIX +3.4% . IOVA +2.3% . PTI +1.9% . TVIX +1.8% . RBBN +1.6% . More news on: CONSOL Energy Inc., Iovance Biotherapeutics, Inc., Proteostasis Therapeutics, Stocks on the move, , News on ETFs, Read more ...
Source: SeekingAlpha
Date: March, 09 2018 17:38
Biotech Forum Daily Digest For March 7th
Love all, trust a few, do wrong to none .” ― William Shakespeare The choppy nature of the market continues. After posting slight gains on Tuesday, the main biotech indices will open substantially down today as will the rest of the overall market. Today's rally killer is t...
Source: SeekingAlpha
Date: March, 07 2018 09:33

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-177.267.207.507.19474,770
2017-03-106.276.356.356.275,811
2017-03-096.106.256.425.9637,104
2017-03-086.016.086.1896.0128,214
2017-03-075.935.986.005.8532,360

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-2142,655129,30932.9869Cover
2018-08-2037,447130,99028.5877Cover
2018-08-1723,061121,98418.9049Cover
2018-08-1640,00383,93547.6595Short
2018-08-1538,98091,06242.8060Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on TTOO.


About T2 Biosystems, Inc. (NASDAQ: TTOO)

Logo for T2 Biosystems, Inc. (NASDAQ: TTOO)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: TTOO)

      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 17 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 11 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 08 2018
      Official notification to shareholders of matters to be brought to a vote (Proxy)
      Filing Type: DEF 14AFiling Source: edgar
      Filing Date: April, 26 2018
      Additional proxy soliciting materials - definitive
      Filing Type: DEFA14AFiling Source: edgar
      Filing Date: April, 26 2018
      Filing Type: CT ORDERFiling Source: edgar
      Filing Date: March, 27 2018
      Annual report with a comprehensive overview of the company
      Filing Type: 10-KFiling Source: edgar
      Filing Date: March, 19 2018
      Notification that form 10-K will be submitted late
      Filing Type: NT 10-KFiling Source: edgar
      Filing Date: March, 19 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 09 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 09 2018

       

       


      Daily Technical Chart for (NASDAQ: TTOO)

      Daily Technical Chart for (NASDAQ: TTOO)


      Stay tuned for daily updates and more on (NASDAQ: TTOO)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: TTOO)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in TTOO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of TTOO and does not buy, sell, or trade any shares of TTOO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/